You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《高盛认股证牛熊证》平安好医生冲70元 再创新高 留意少数贴价购20493
阿思达克 01-22 11:02

正股表现:平安好医生(1833)自上周三起开始连升,今早继续上升,最高见70.7元,继昨日再创上市新高。现报69.9元,升约4.3%,而上周三累计至今则升约16%。有券商指平安好医生去年下半年收入按年增长18%,并料会员制可带动高毛利网上医疗服务,及明年业绩可亏转盈。该行维持「跑嬴大市」评级,目标价78元。

资金流向:观察个股认股证资金流向,可见上周四至本周一皆录得资流入,合共约300万元。昨日则见资金转向沽出。

产品选择:可见大部分的产品提供的杠杆都在约3至4倍杠杆。因此投资者计划部署认购证,可考虑选择较贴价条款的产品。但由於股价急升,市场上价外认购证所余无几,可留意当中少数贴价的平医购20493。

平医购20493,行使价70.93元,2020年06月22日到期,实际杠杆3.2倍,市场上少数贴价认购证

注: 以上数据资料来自高盛认股证牛熊证网站~重要声明:

以上资讯由第三方提供,AASTOCKS.com Limited对於任何包含於、经由、连结、下载或从任何与本网站有关服务所获得之资讯、内容或广告,不声明或保证其内容之正确性或可靠性。对於您透过本网站上之广告、资讯或要约而展示、购买或取得之任何产品、资讯资料,本公司亦不负品质保证之责任。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.
uSMART
Wealth Growth Made Easy
Open Account